Abstract
Think there's nothing new in the world of flow cytometry? Think again. As industry powerhouses like BD Biosciences and Beckman Coulter continually redefine the technology's bleeding edge, upstarts have emerged with innovative technologies of their own. And not only upstarts. No less a corporate brand than Sony entered the fray this past February with the purchase of flow cytometry firm iCyt. As Richard Konz, director of the University of Massachusetts Medical School Flow Cytometry Core Facility, explains, the technology has shaken off its immunology roots to become a multidisciplinary tool. "Literally every department is using flow for something, and that for me is very exciting," Konz says. "It's basically never a dull moment."
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
